Institutional

Weill Cornell Medicine honored 18 faculty, trainees, students and staff April 23 for their outstanding service and leadership in promoting diversity at the academic medical institution.

Academic medical institutions must champion faculty diversity if they are to improve outcomes for patients, according to a National Institutes of Health diversity leader who delivered the keynote address at Weill Cornell Medicine’s inaugural Diversity Week.

Dr. Elizabeth Ross has an enduring passion for improving patients’ lives by studying how genes affect the brain’s function.

For Dr. Ernie Esquivel, director of Weill Cornell Medical College’s internal medicine clerkship, there are few things more gratifying than watching medical students succeed in their training.

Dr. Jean William “Bill” Pape, the Howard and Carol Holtzmann Professor in Clinical Medicine and the founder and director of GHESKIO in Haiti, has been awarded the inaugural Joan and Sanford I. Weill Exemplary Achievement Award from Weill Cornell Medicine.

Researchers at Weill Cornell Medicine and Cornell's Ithaca campus have established a new center to better understand why health outcomes vary among demographic groups.

For Weill Cornell Medicine, 1998 was a banner year. Amid its centennial celebration, the academic medical institution renamed itself in deep appreciation for Joan and Sanford I. Weill and their exemplary leadership, launching a bright, new era of dynamic expansion. 

As a student in the Tri-Institutional MD-PhD program, Dr. Joseph Heitman, MD ’92,  was thrilled to be training as a physician-scientist—someone who would be, as he puts it, an “ambassador” to bridge the sometimes disparate worlds of medicine and basic research.

Dr. Vijay Sankaran, a physician-scientist who investigates the molecular underpinnings of pediatric genetic blood disorders, has been awarded the third annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today.

Weill Cornell Medicine’s BioVenture eLab, a hub of the institution’s entrepreneurial activity celebrated a milestone on Jan. 23: the official launch of its new name and the opening of its dedicated space at 1157 York Ave.

When the Tri-Institutional Therapeutics Discovery Institute launched just over four years ago, nothing like it existed in academia. 

Mark Veich, an accomplished leader in institutional advancement, has been appointed vice provost for external affairs at Weill Cornell Medicine, effective Feb. 12.

For physician-scientist Dr. Virginia Pascual research was a revelation. 

Ongoing monitoring for genetic changes in chronic lymphocytic leukemia (CLL) during targeted treatment may allow clinicians to adjust patients’ treatments as the cancer evolves, according to a study in Nature Communications led by Weill Cornell Medicine and New York Genome Center scientists.

Weill Cornell Medicine has been awarded a $4 million, four-year grant from the National Institute of Mental Health of the National Institutes of Health to support a new research center dedicated to developing and studying improved treatments for middle-age and older adults suffering from depression.

Dr. Said Ibrahim, a leading physician-scientist whose research focuses on healthcare disparities, has been named the inaugural chief of the newly established Division of Healthcare Delivery Science and Innovation in the Department of Healthcare Policy and Research at Weill Cornell Medicine, effective Feb. 1.

Weill Cornell Medicine researchers have received a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to conduct an in-depth study of the mechanisms that cause scar tissue to form in the lung and kidney.

Dr. Anthony Hollenberg, a leading physician-scientist specializing in endocrinology, has been appointed chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective Feb. 1.